Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of ETHERNA IMMUNOTHERAPIES is 0.5% (low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publicationslatest 18-03-2025
49
publications in the State GazetteArticles of association amended — translation of the articles, coordination of the articles and amendment of specific…All publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsEstablished
Founded in 2013 — 13 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.5%
Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units
+Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies70200Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering70220Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameNL | ETHERNA IMMUNOTHERAPIES |
Registered office
Galileilaan 19
2845 Niel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.